Dose schedule modifications for specific goals While the standard schedule targets 12mg maintenance, not every researcher aims for the same outcome
If a patient titrates onto semaglutide, tolerates poorly, switches to tirzepatide at month three, and re-titrates from the bottom, the $25/month calculation already includes two failed PA cycles and three months of co-pays without meaningful clinical progress
In the process of physiological ageing, both systemic and tissue-specific systems show functional downfalls, which, when projected to the brain, translate into weakening defence and metabolic strain resulting from age-dependent declines of the cardio-vascular system and overall decreases in metabolism
The gap is not subtle at the top of the dose range
References: (1) Gentinetta, S., et al